

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * modulation by symbiont of host defense response (GO:0052031) | 7.13059569 |
| 2 | * modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.13059569 |
| 3 | * modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.13059569 |
| 4 | * positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.13059569 |
| 5 | * modulation by symbiont of host immune response (GO:0052553) | 7.13059569 |
| 6 | * positive regulation by symbiont of host defense response (GO:0052509) | 7.13059569 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.49129070 |
| 8 | * regulation of interferon-beta biosynthetic process (GO:0045357) | 6.20387281 |
| 9 | * macrophage activation involved in immune response (GO:0002281) | 5.59400219 |
| 10 | * microglial cell activation (GO:0001774) | 5.28136589 |
| 11 | * positive regulation of interferon-alpha production (GO:0032727) | 5.12386412 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.04413225 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.86930214 |
| 14 | * regulation of interferon-alpha production (GO:0032647) | 4.84418014 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.84081568 |
| 16 | response to peptidoglycan (GO:0032494) | 4.57813081 |
| 17 | * response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.44526925 |
| 18 | * response to host immune response (GO:0052572) | 4.44526925 |
| 19 | detection of other organism (GO:0098543) | 4.27869531 |
| 20 | B cell proliferation (GO:0042100) | 4.24722297 |
| 21 | NIK/NF-kappaB signaling (GO:0038061) | 4.21178782 |
| 22 | detection of bacterium (GO:0016045) | 4.17744663 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16224333 |
| 24 | T cell migration (GO:0072678) | 4.15078668 |
| 25 | respiratory burst (GO:0045730) | 4.14452913 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.13277244 |
| 27 | * macrophage activation (GO:0042116) | 4.09835515 |
| 28 | positive regulation of antigen processing and presentation (GO:0002579) | 4.08028844 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.06276199 |
| 30 | * response to host (GO:0075136) | 4.05479306 |
| 31 | * response to host defenses (GO:0052200) | 4.05479306 |
| 32 | * response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.05479306 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.99125222 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.90895124 |
| 35 | * myeloid cell activation involved in immune response (GO:0002275) | 3.88276694 |
| 36 | * positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.87708761 |
| 37 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.87463221 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.81190982 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.79670341 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.79670341 |
| 41 | positive thymic T cell selection (GO:0045059) | 3.77676973 |
| 42 | granulocyte activation (GO:0036230) | 3.75389857 |
| 43 | T-helper 1 type immune response (GO:0042088) | 3.71779734 |
| 44 | * positive regulation of interferon-beta production (GO:0032728) | 3.71369819 |
| 45 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.71069186 |
| 46 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.69013484 |
| 47 | positive regulation of B cell differentiation (GO:0045579) | 3.68610885 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68336548 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.67307237 |
| 50 | pinocytosis (GO:0006907) | 3.65690634 |
| 51 | negative T cell selection (GO:0043383) | 3.65545454 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.64501273 |
| 53 | neutrophil activation (GO:0042119) | 3.61242218 |
| 54 | cellular response to interferon-gamma (GO:0071346) | 3.57606518 |
| 55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.54354601 |
| 56 | negative regulation of interleukin-17 production (GO:0032700) | 3.50979017 |
| 57 | response to protozoan (GO:0001562) | 3.50883114 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.50363399 |
| 59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50363399 |
| 60 | B cell homeostasis (GO:0001782) | 3.49603976 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47449580 |
| 62 | cellular extravasation (GO:0045123) | 3.43506210 |
| 63 | B cell mediated immunity (GO:0019724) | 3.43374048 |
| 64 | positive regulation of humoral immune response (GO:0002922) | 3.36739177 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 3.36621496 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.36426373 |
| 67 | response to type I interferon (GO:0034340) | 3.36252462 |
| 68 | type I interferon signaling pathway (GO:0060337) | 3.36160515 |
| 69 | cellular response to type I interferon (GO:0071357) | 3.36160515 |
| 70 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.33826583 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 3.32333882 |
| 72 | response to muramyl dipeptide (GO:0032495) | 3.32099914 |
| 73 | regulation of hypersensitivity (GO:0002883) | 3.30018695 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 3.28571244 |
| 75 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.28003492 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 3.27923744 |
| 77 | negative regulation of granulocyte differentiation (GO:0030853) | 3.27889573 |
| 78 | detection of biotic stimulus (GO:0009595) | 3.27444594 |
| 79 | * positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.27366724 |
| 80 | response to interferon-gamma (GO:0034341) | 3.24381677 |
| 81 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.23218648 |
| 82 | regulation of interleukin-12 production (GO:0032655) | 3.19404663 |
| 83 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.19007733 |
| 84 | regulation of mononuclear cell migration (GO:0071675) | 3.18973813 |
| 85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.17123802 |
| 86 | positive regulation of chemokine secretion (GO:0090197) | 3.15783419 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15752289 |
| 88 | regulation of B cell proliferation (GO:0030888) | 3.15633396 |
| 89 | positive regulation of B cell mediated immunity (GO:0002714) | 3.14311536 |
| 90 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.14311536 |
| 91 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.14087669 |
| 92 | natural killer cell mediated immunity (GO:0002228) | 3.13609735 |
| 93 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.13609735 |
| 94 | interferon-gamma production (GO:0032609) | 3.12398482 |
| 95 | positive regulation of type 2 immune response (GO:0002830) | 3.11399782 |
| 96 | positive regulation of B cell proliferation (GO:0030890) | 3.10318458 |
| 97 | positive regulation of mast cell activation (GO:0033005) | 3.10057389 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09997769 |
| 99 | cellular response to exogenous dsRNA (GO:0071360) | 3.09180500 |
| 100 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.09100107 |
| 101 | positive regulation of macrophage cytokine production (GO:0060907) | 3.08988662 |
| 102 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.08591831 |
| 103 | * I-kappaB phosphorylation (GO:0007252) | 3.07321695 |
| 104 | regulation of B cell differentiation (GO:0045577) | 3.07133808 |
| 105 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.06198985 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 3.05660216 |
| 107 | T cell selection (GO:0045058) | 3.05616143 |
| 108 | regulation of germinal center formation (GO:0002634) | 3.05432906 |
| 109 | thymic T cell selection (GO:0045061) | 3.05189970 |
| 110 | adaptive immune response (GO:0002250) | 3.04796573 |
| 111 | regulation of mast cell activation (GO:0033003) | 3.03377659 |
| 112 | negative regulation of interleukin-12 production (GO:0032695) | 3.01958984 |
| 113 | natural killer cell activation involved in immune response (GO:0002323) | 3.00817184 |
| 114 | * myeloid leukocyte activation (GO:0002274) | 3.00367810 |
| 115 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99210090 |
| 116 | detection of molecule of bacterial origin (GO:0032490) | 2.98615386 |
| 117 | cellular response to interferon-beta (GO:0035458) | 2.98144332 |
| 118 | negative regulation of innate immune response (GO:0045824) | 2.98016827 |
| 119 | T cell costimulation (GO:0031295) | 2.95575843 |
| 120 | positive T cell selection (GO:0043368) | 2.95013757 |
| 121 | neutrophil mediated immunity (GO:0002446) | 2.94842881 |
| 122 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.93344560 |
| 123 | response to interferon-alpha (GO:0035455) | 2.92126726 |
| 124 | germinal center formation (GO:0002467) | 2.91627287 |
| 125 | defense response to protozoan (GO:0042832) | 2.91611694 |
| 126 | negative regulation of B cell proliferation (GO:0030889) | 2.89980610 |
| 127 | negative regulation of mast cell activation (GO:0033004) | 2.87341225 |
| 128 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86868137 |
| 129 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.82016420 |
| 130 | positive regulation of mast cell degranulation (GO:0043306) | 2.80324010 |
| 131 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.80324010 |
| 132 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.78365527 |
| 133 | neutrophil chemotaxis (GO:0030593) | 2.78029129 |
| 134 | cellular response to interferon-alpha (GO:0035457) | 2.77756518 |
| 135 | regulation of leukocyte degranulation (GO:0043300) | 2.76334854 |
| 136 | mature B cell differentiation (GO:0002335) | 2.74913584 |
| 137 | * regulation of interferon-beta production (GO:0032648) | 2.74805203 |
| 138 | cytokine secretion (GO:0050663) | 2.73525901 |
| 139 | glycosphingolipid catabolic process (GO:0046479) | 2.71654494 |
| 140 | neutrophil migration (GO:1990266) | 2.70033669 |
| 141 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.69718176 |
| 142 | positive regulation of interleukin-12 production (GO:0032735) | 2.69483425 |
| 143 | * positive regulation of chemokine production (GO:0032722) | 2.69357728 |
| 144 | hyaluronan catabolic process (GO:0030214) | 2.69242107 |
| 145 | lymphocyte chemotaxis (GO:0048247) | 2.68948746 |
| 146 | positive regulation of leukocyte degranulation (GO:0043302) | 2.68519098 |
| 147 | leukocyte mediated cytotoxicity (GO:0001909) | 2.67715914 |
| 148 | mannose metabolic process (GO:0006013) | 2.67212827 |
| 149 | myeloid dendritic cell differentiation (GO:0043011) | 2.66878908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.03687285 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.76541305 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.48413697 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.93205259 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.53765468 |
| 6 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.98131846 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.82287438 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.70828485 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.56133445 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.46979976 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.46225344 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.26310789 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.06465048 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.94336557 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80177980 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77835008 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73470435 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.67015248 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.40744293 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.29561189 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.24648910 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24178806 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.18096873 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.13014429 |
| 25 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.12142018 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.11894000 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96089124 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95163662 |
| 29 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.93594907 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90870350 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89597378 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81107503 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.80685156 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79394626 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78584125 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78386398 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.71916683 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71772791 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67583234 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67502247 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66818943 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66070950 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65683364 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59500925 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.53478197 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53211659 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47458409 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46693274 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43391300 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42138461 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41725308 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34887188 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31316425 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30678046 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.30231817 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28065441 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27215950 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27105778 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25645869 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24154216 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20942282 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18733680 |
| 63 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17253802 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16588294 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14804361 |
| 66 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.11818509 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11747093 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10767732 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07859306 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05447425 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05359062 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03273497 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02355947 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98875504 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96042035 |
| 76 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95891058 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95086531 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93878606 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93045273 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92739060 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92590204 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92468536 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 0.90717792 |
| 84 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.90409025 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88394831 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87568009 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86045183 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86033399 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84560605 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84257119 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84202110 |
| 92 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82712955 |
| 93 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.77229153 |
| 94 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77206642 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76312204 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75140052 |
| 97 | * P300_27268052_Chip-Seq_Bcells_Human | 0.75026946 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74732798 |
| 99 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73180767 |
| 100 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.72072106 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71800718 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71017058 |
| 103 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.68999656 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68824498 |
| 105 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68336711 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66432715 |
| 107 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.66254421 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.65909399 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.64248519 |
| 110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.63788121 |
| 111 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.63710575 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.63198166 |
| 113 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.61468760 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.61071388 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58629396 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57984316 |
| 117 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.57291613 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56720380 |
| 119 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56514336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.41541852 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.39160478 |
| 3 | MP0003303_peritoneal_inflammation | 3.79848485 |
| 4 | MP0006082_CNS_inflammation | 3.73428536 |
| 5 | MP0003436_decreased_susceptibility_to | 3.37180614 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.31069422 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.10156938 |
| 8 | * MP0005000_abnormal_immune_tolerance | 2.93853835 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.86307076 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.81716757 |
| 11 | MP0001790_abnormal_immune_system | 2.73558059 |
| 12 | MP0005387_immune_system_phenotype | 2.73558059 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.71533450 |
| 14 | MP0009785_altered_susceptibility_to | 2.68914601 |
| 15 | * MP0001800_abnormal_humoral_immune | 2.60984879 |
| 16 | MP0005025_abnormal_response_to | 2.58270879 |
| 17 | MP0005671_abnormal_response_to | 2.56585976 |
| 18 | MP0009840_abnormal_foam_cell | 2.50749863 |
| 19 | * MP0002723_abnormal_immune_serum | 2.47589212 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.37040151 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.36942008 |
| 22 | MP0000685_abnormal_immune_system | 2.36799999 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.29279165 |
| 24 | MP0003724_increased_susceptibility_to | 2.24744311 |
| 25 | * MP0001819_abnormal_immune_cell | 2.20288986 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 2.18731453 |
| 27 | MP0004510_myositis | 2.15042519 |
| 28 | MP0001533_abnormal_skeleton_physiology | 2.06328860 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.00369683 |
| 30 | MP0003690_abnormal_glial_cell | 1.86387702 |
| 31 | MP0002405_respiratory_system_inflammati | 1.82281452 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.79207797 |
| 33 | MP0004947_skin_inflammation | 1.76371398 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.75837165 |
| 35 | MP0001853_heart_inflammation | 1.74510857 |
| 36 | MP0000604_amyloidosis | 1.72811245 |
| 37 | MP0009278_abnormal_bone_marrow | 1.70120983 |
| 38 | MP0003075_altered_response_to | 1.68253893 |
| 39 | * MP0000716_abnormal_immune_system | 1.63914756 |
| 40 | * MP0008469_abnormal_protein_level | 1.63436141 |
| 41 | MP0000343_altered_response_to | 1.55524392 |
| 42 | MP0002398_abnormal_bone_marrow | 1.54612381 |
| 43 | * MP0000689_abnormal_spleen_morphology | 1.51097484 |
| 44 | MP0005310_abnormal_salivary_gland | 1.48998032 |
| 45 | MP0003448_altered_tumor_morphology | 1.48682391 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.42177862 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.36289737 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.35834899 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.34647853 |
| 50 | * MP0002429_abnormal_blood_cell | 1.32590426 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.32377819 |
| 52 | MP0010307_abnormal_tumor_latency | 1.30998983 |
| 53 | MP0005166_decreased_susceptibility_to | 1.30899773 |
| 54 | MP0002722_abnormal_immune_system | 1.30697481 |
| 55 | MP0009764_decreased_sensitivity_to | 1.30335322 |
| 56 | MP0001851_eye_inflammation | 1.27997644 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.27519608 |
| 58 | MP0002006_tumorigenesis | 1.23431363 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.21168893 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.13797444 |
| 61 | MP0002163_abnormal_gland_morphology | 1.12667501 |
| 62 | MP0005451_abnormal_body_composition | 1.12372148 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.08911397 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.08911397 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.06155978 |
| 66 | MP0000858_altered_metastatic_potential | 1.06117098 |
| 67 | MP0003828_pulmonary_edema | 1.05425464 |
| 68 | MP0001873_stomach_inflammation | 1.03413214 |
| 69 | MP0002933_joint_inflammation | 1.02604348 |
| 70 | MP0002254_reproductive_system_inflammat | 1.00763557 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.00338643 |
| 72 | MP0003866_abnormal_defecation | 0.99692698 |
| 73 | MP0005257_abnormal_intraocular_pressure | 0.96334390 |
| 74 | MP0003195_calcinosis | 0.95716276 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 0.95627448 |
| 76 | MP0005390_skeleton_phenotype | 0.93993262 |
| 77 | MP0002396_abnormal_hematopoietic_system | 0.90143019 |
| 78 | MP0005164_abnormal_response_to | 0.87176391 |
| 79 | MP0002090_abnormal_vision | 0.86850517 |
| 80 | MP0001663_abnormal_digestive_system | 0.85303608 |
| 81 | MP0000249_abnormal_blood_vessel | 0.83959869 |
| 82 | MP0009763_increased_sensitivity_to | 0.83107977 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.81666299 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 0.81476511 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.79087377 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.78567906 |
| 87 | MP0005076_abnormal_cell_differentiation | 0.78033776 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 0.75153389 |
| 89 | MP0003091_abnormal_cell_migration | 0.74628979 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.74172885 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.73680440 |
| 92 | MP0004883_abnormal_blood_vessel | 0.73283995 |
| 93 | MP0000371_diluted_coat_color | 0.73154043 |
| 94 | MP0008260_abnormal_autophagy | 0.73091330 |
| 95 | MP0003763_abnormal_thymus_physiology | 0.72087713 |
| 96 | MP0003045_fibrosis | 0.70766897 |
| 97 | MP0000920_abnormal_myelination | 0.69350665 |
| 98 | MP0000703_abnormal_thymus_morphology | 0.68590612 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.68497849 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.68301266 |
| 101 | MP0003795_abnormal_bone_structure | 0.68071647 |
| 102 | MP0004185_abnormal_adipocyte_glucose | 0.67411931 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 0.65492983 |
| 104 | MP0001915_intracranial_hemorrhage | 0.64498241 |
| 105 | MP0005023_abnormal_wound_healing | 0.64182533 |
| 106 | MP0002928_abnormal_bile_duct | 0.63701711 |
| 107 | MP0000609_abnormal_liver_physiology | 0.63032745 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 0.62802966 |
| 109 | MP0000490_abnormal_crypts_of | 0.61628695 |
| 110 | MP0008004_abnormal_stomach_pH | 0.61572171 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.61529696 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.61022824 |
| 113 | MP0001958_emphysema | 0.60738813 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.60476721 |
| 115 | MP0008873_increased_physiological_sensi | 0.58827408 |
| 116 | MP0008874_decreased_physiological_sensi | 0.57361749 |
| 117 | MP0004130_abnormal_muscle_cell | 0.55993724 |
| 118 | MP0004381_abnormal_hair_follicle | 0.55952392 |
| 119 | MP0003252_abnormal_bile_duct | 0.50498994 |
| 120 | MP0009115_abnormal_fat_cell | 0.49405244 |
| 121 | MP0008872_abnormal_physiological_respon | 0.49293950 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.48549590 |
| 123 | MP0003806_abnormal_nucleotide_metabolis | 0.47663837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.54580493 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.45764470 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.98708586 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.93975717 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.79111765 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.25401319 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.08106539 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.03000968 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.03000968 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 5.03000968 |
| 11 | Agammaglobulinemia (HP:0004432) | 5.01986964 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.88522884 |
| 13 | Glomerulonephritis (HP:0000099) | 4.79304371 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.67725915 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.55421585 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.38350045 |
| 17 | Disinhibition (HP:0000734) | 4.37553427 |
| 18 | Recurrent bronchitis (HP:0002837) | 4.17493901 |
| 19 | Recurrent sinusitis (HP:0011108) | 3.88320311 |
| 20 | Axonal loss (HP:0003447) | 3.83884838 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.70759516 |
| 22 | Recurrent skin infections (HP:0001581) | 3.65275597 |
| 23 | Encephalitis (HP:0002383) | 3.62382716 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.62126934 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.62126934 |
| 26 | Lymphopenia (HP:0001888) | 3.58540768 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.53873150 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.52341246 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.47296822 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.47296822 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.47296822 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.46968326 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 3.46742492 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.38509587 |
| 35 | IgA deficiency (HP:0002720) | 3.37382496 |
| 36 | Increased IgM level (HP:0003496) | 3.28252261 |
| 37 | Gingivitis (HP:0000230) | 3.27730930 |
| 38 | Complement deficiency (HP:0004431) | 3.25468092 |
| 39 | Myositis (HP:0100614) | 3.24893950 |
| 40 | Obstructive lung disease (HP:0006536) | 3.23181014 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 3.23181014 |
| 42 | Recurrent fungal infections (HP:0002841) | 3.22450200 |
| 43 | Hematochezia (HP:0002573) | 3.20269052 |
| 44 | Agnosia (HP:0010524) | 3.12810800 |
| 45 | IgG deficiency (HP:0004315) | 3.09528910 |
| 46 | Recurrent viral infections (HP:0004429) | 3.05837182 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 3.04899660 |
| 48 | Loss of speech (HP:0002371) | 3.04673119 |
| 49 | Stomatitis (HP:0010280) | 2.99450394 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.99106354 |
| 51 | IgM deficiency (HP:0002850) | 2.96951082 |
| 52 | Colitis (HP:0002583) | 2.96155337 |
| 53 | Cellulitis (HP:0100658) | 2.94662801 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.93531612 |
| 55 | Hemoptysis (HP:0002105) | 2.92714129 |
| 56 | Nephritis (HP:0000123) | 2.88086712 |
| 57 | Myocardial infarction (HP:0001658) | 2.87732686 |
| 58 | Basal ganglia calcification (HP:0002135) | 2.85492623 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.84213833 |
| 60 | Abnormality of T cells (HP:0002843) | 2.83509355 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.80195567 |
| 62 | Abnormality of complement system (HP:0005339) | 2.80190051 |
| 63 | Orchitis (HP:0100796) | 2.79758144 |
| 64 | Mutism (HP:0002300) | 2.76911942 |
| 65 | Vasculitis (HP:0002633) | 2.76443826 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.75528755 |
| 67 | Abnormality of T cell number (HP:0011839) | 2.75017818 |
| 68 | Hepatosplenomegaly (HP:0001433) | 2.70613796 |
| 69 | Upper motor neuron abnormality (HP:0002127) | 2.70355414 |
| 70 | Increased IgE level (HP:0003212) | 2.69484060 |
| 71 | Restrictive lung disease (HP:0002091) | 2.68218301 |
| 72 | Retinal atrophy (HP:0001105) | 2.65985747 |
| 73 | Papilloma (HP:0012740) | 2.61800740 |
| 74 | Verrucae (HP:0200043) | 2.61800740 |
| 75 | Inflammation of the large intestine (HP:0002037) | 2.60847177 |
| 76 | Prostate neoplasm (HP:0100787) | 2.60652695 |
| 77 | Emphysema (HP:0002097) | 2.59680298 |
| 78 | Osteomyelitis (HP:0002754) | 2.57837903 |
| 79 | T lymphocytopenia (HP:0005403) | 2.52618620 |
| 80 | Pustule (HP:0200039) | 2.50524687 |
| 81 | Abnormality of B cell number (HP:0010975) | 2.44194935 |
| 82 | Global brain atrophy (HP:0002283) | 2.43896031 |
| 83 | Periodontitis (HP:0000704) | 2.43892700 |
| 84 | Thick nail (HP:0001805) | 2.43522161 |
| 85 | Sepsis (HP:0100806) | 2.43403698 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 2.42521977 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.41821946 |
| 88 | Optic neuritis (HP:0100653) | 2.41821946 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.40705731 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.40705731 |
| 91 | Arterial tortuosity (HP:0005116) | 2.39184699 |
| 92 | Pathologic fracture (HP:0002756) | 2.38205440 |
| 93 | Chronic otitis media (HP:0000389) | 2.36800525 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 2.35535056 |
| 95 | Inappropriate behavior (HP:0000719) | 2.35161336 |
| 96 | Spontaneous hematomas (HP:0007420) | 2.34662173 |
| 97 | Chest pain (HP:0100749) | 2.33701590 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.32812355 |
| 99 | Cerebral aneurysm (HP:0004944) | 2.31268809 |
| 100 | Bronchitis (HP:0012387) | 2.30919832 |
| 101 | Skin rash (HP:0000988) | 2.30411703 |
| 102 | Abnormality of the pleura (HP:0002103) | 2.28455532 |
| 103 | Recurrent pneumonia (HP:0006532) | 2.26762843 |
| 104 | Meningitis (HP:0001287) | 2.25885571 |
| 105 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.25427949 |
| 106 | Chronic sinusitis (HP:0011109) | 2.22662638 |
| 107 | Thoracic kyphosis (HP:0002942) | 2.22108183 |
| 108 | Osteolytic defects of the hand bones (HP:0009699) | 2.20392146 |
| 109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.20392146 |
| 110 | Arthralgia (HP:0002829) | 2.19858660 |
| 111 | Autoimmune hemolytic anemia (HP:0001890) | 2.19263298 |
| 112 | Pulmonary infiltrates (HP:0002113) | 2.18941842 |
| 113 | Urticaria (HP:0001025) | 2.18815257 |
| 114 | B lymphocytopenia (HP:0010976) | 2.18711922 |
| 115 | Peripheral demyelination (HP:0011096) | 2.16726603 |
| 116 | Gangrene (HP:0100758) | 2.13587989 |
| 117 | Cheilitis (HP:0100825) | 2.13226906 |
| 118 | Leukopenia (HP:0001882) | 2.12196095 |
| 119 | J-shaped sella turcica (HP:0002680) | 2.11305558 |
| 120 | Granulocytopenia (HP:0001913) | 2.11181033 |
| 121 | Abnormality of the prostate (HP:0008775) | 2.10609611 |
| 122 | Leukocytosis (HP:0001974) | 2.08617330 |
| 123 | Abnormality of eosinophils (HP:0001879) | 2.08194608 |
| 124 | Pulmonary embolism (HP:0002204) | 2.07475013 |
| 125 | Anorexia (HP:0002039) | 2.06958057 |
| 126 | Asymmetric septal hypertrophy (HP:0001670) | 2.06109351 |
| 127 | Vascular tortuosity (HP:0004948) | 2.04307598 |
| 128 | Lymphoma (HP:0002665) | 2.03960998 |
| 129 | Chronic diarrhea (HP:0002028) | 2.02602896 |
| 130 | Polyneuropathy (HP:0001271) | 2.02120708 |
| 131 | Increased CSF protein (HP:0002922) | 2.01037360 |
| 132 | Bone pain (HP:0002653) | 2.00995492 |
| 133 | Conjunctival telangiectasia (HP:0000524) | 2.00939126 |
| 134 | Diminished motivation (HP:0000745) | 2.00467274 |
| 135 | Abnormality of the lumbar spine (HP:0100712) | 2.00171836 |
| 136 | Apathy (HP:0000741) | 1.99539887 |
| 137 | Arterial thrombosis (HP:0004420) | 1.98910470 |
| 138 | Spondylolisthesis (HP:0003302) | 1.98761793 |
| 139 | Progressive visual loss (HP:0000529) | 1.95378841 |
| 140 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94169742 |
| 141 | Progressive neurologic deterioration (HP:0002344) | 1.92943916 |
| 142 | Gingival bleeding (HP:0000225) | 1.90263001 |
| 143 | Personality changes (HP:0000751) | 1.88317716 |
| 144 | Tetraparesis (HP:0002273) | 1.86473108 |
| 145 | Gastrointestinal stroma tumor (HP:0100723) | 1.85372170 |
| 146 | Eosinophilia (HP:0001880) | 1.83953707 |
| 147 | Petechiae (HP:0000967) | 1.82131488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.22594837 |
| 2 | BLK | 3.93804659 |
| 3 | TYK2 | 3.57901587 |
| 4 | RIPK4 | 3.39169956 |
| 5 | MAP4K1 | 3.37243801 |
| 6 | TBK1 | 3.08067516 |
| 7 | CSF1R | 2.80938842 |
| 8 | ERN1 | 2.78448644 |
| 9 | IRAK4 | 2.77871224 |
| 10 | KIT | 2.74147837 |
| 11 | MAP3K14 | 2.64948913 |
| 12 | PRPF4B | 2.27923706 |
| 13 | JAK1 | 2.24541953 |
| 14 | IRAK3 | 2.12828817 |
| 15 | CAMK1D | 1.95605202 |
| 16 | IKBKE | 1.93764585 |
| 17 | IKBKB | 1.80812140 |
| 18 | ZAP70 | 1.75420677 |
| 19 | GRK7 | 1.71467566 |
| 20 | HCK | 1.66548377 |
| 21 | STK10 | 1.63711885 |
| 22 | TXK | 1.61508483 |
| 23 | SYK | 1.61003969 |
| 24 | CSK | 1.59906544 |
| 25 | MAP3K13 | 1.58872107 |
| 26 | FES | 1.58414773 |
| 27 | JAK3 | 1.54623864 |
| 28 | CAMK1G | 1.37070349 |
| 29 | NEK9 | 1.36143627 |
| 30 | LYN | 1.33600828 |
| 31 | MAPK15 | 1.32437066 |
| 32 | TAOK3 | 1.25442110 |
| 33 | LCK | 1.25336597 |
| 34 | EPHB1 | 1.25294209 |
| 35 | MATK | 1.24088170 |
| 36 | FGR | 1.21338920 |
| 37 | BTK | 1.20402629 |
| 38 | TNK2 | 1.19326785 |
| 39 | ITK | 1.18596278 |
| 40 | SIK3 | 1.15148501 |
| 41 | SIK2 | 1.14418142 |
| 42 | SCYL2 | 1.14097889 |
| 43 | MAP2K3 | 1.12072960 |
| 44 | JAK2 | 1.11210423 |
| 45 | TLK1 | 1.09506226 |
| 46 | TRIB3 | 1.07549380 |
| 47 | FRK | 1.06757765 |
| 48 | MAP3K10 | 1.01975983 |
| 49 | CLK1 | 1.00056231 |
| 50 | MARK3 | 0.97154720 |
| 51 | PAK4 | 0.94471947 |
| 52 | PBK | 0.92924908 |
| 53 | TEC | 0.90085109 |
| 54 | RPS6KA4 | 0.87030721 |
| 55 | CDC42BPA | 0.87004695 |
| 56 | PKN2 | 0.86237528 |
| 57 | CHUK | 0.85223651 |
| 58 | CAMKK2 | 0.84674607 |
| 59 | RIPK1 | 0.82595703 |
| 60 | EGFR | 0.75779232 |
| 61 | FGFR3 | 0.73634663 |
| 62 | PTK6 | 0.72990356 |
| 63 | FGFR4 | 0.71981288 |
| 64 | GRK6 | 0.71526573 |
| 65 | PIM2 | 0.68545302 |
| 66 | CDK12 | 0.68068424 |
| 67 | PIM1 | 0.68044576 |
| 68 | LRRK2 | 0.67673042 |
| 69 | MOS | 0.67580021 |
| 70 | ACVR1B | 0.67164900 |
| 71 | TTN | 0.66738982 |
| 72 | MAP3K3 | 0.62929969 |
| 73 | MAPK11 | 0.62784352 |
| 74 | CDK6 | 0.60395522 |
| 75 | ABL1 | 0.59896325 |
| 76 | MAP3K1 | 0.58861022 |
| 77 | PRKCD | 0.58404883 |
| 78 | CDK4 | 0.57769195 |
| 79 | STK4 | 0.57318143 |
| 80 | PDK1 | 0.54180630 |
| 81 | MAPK12 | 0.50190474 |
| 82 | CCNB1 | 0.49857620 |
| 83 | TRPM7 | 0.49739201 |
| 84 | CAMKK1 | 0.47200279 |
| 85 | FYN | 0.45273961 |
| 86 | CDK19 | 0.45235197 |
| 87 | HIPK2 | 0.44589839 |
| 88 | IGF1R | 0.43450295 |
| 89 | ADRBK2 | 0.43280957 |
| 90 | MAPKAPK2 | 0.42887901 |
| 91 | PDPK1 | 0.42644290 |
| 92 | STK24 | 0.42486106 |
| 93 | BMX | 0.41859653 |
| 94 | PRKCH | 0.41666810 |
| 95 | BMPR2 | 0.40837826 |
| 96 | MELK | 0.40495587 |
| 97 | KSR2 | 0.39598645 |
| 98 | PRKCQ | 0.39536432 |
| 99 | EIF2AK2 | 0.39367379 |
| 100 | RPS6KA5 | 0.39096299 |
| 101 | MAP3K5 | 0.38544624 |
| 102 | IRAK1 | 0.38413093 |
| 103 | YES1 | 0.35942277 |
| 104 | INSR | 0.35559696 |
| 105 | TAOK1 | 0.35167410 |
| 106 | MAPK7 | 0.35114845 |
| 107 | OXSR1 | 0.34771781 |
| 108 | TAOK2 | 0.34286696 |
| 109 | PIK3CG | 0.34235253 |
| 110 | IRAK2 | 0.33401496 |
| 111 | EIF2AK3 | 0.32877088 |
| 112 | PKN1 | 0.32461111 |
| 113 | GSK3A | 0.31562224 |
| 114 | NME2 | 0.30900783 |
| 115 | PDGFRB | 0.30699961 |
| 116 | PASK | 0.29724664 |
| 117 | ABL2 | 0.28723483 |
| 118 | EPHA3 | 0.28679930 |
| 119 | MAP3K11 | 0.28644395 |
| 120 | STK11 | 0.26872738 |
| 121 | DAPK2 | 0.26308940 |
| 122 | PRKCZ | 0.25379683 |
| 123 | MAP2K1 | 0.25037041 |
| 124 | STK3 | 0.24978731 |
| 125 | SMG1 | 0.24963837 |
| 126 | NLK | 0.24621006 |
| 127 | MAP3K9 | 0.24580272 |
| 128 | MAPK4 | 0.24488423 |
| 129 | RAF1 | 0.23861903 |
| 130 | SGK2 | 0.23722230 |
| 131 | MAP3K8 | 0.21251062 |
| 132 | SRC | 0.20764667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.85780114 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.55967837 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14401070 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.08182560 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.94557279 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.85400777 |
| 7 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.55432750 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.43113267 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.32183792 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.23598708 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.17216154 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.96638707 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95434912 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.89604324 |
| 15 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.82241758 |
| 16 | * Measles_Homo sapiens_hsa05162 | 1.80466097 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.75210947 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74328954 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73586162 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.70303204 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69328538 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.67989360 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.67940043 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66141201 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60986912 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.59242933 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58630133 |
| 28 | * Influenza A_Homo sapiens_hsa05164 | 1.58413738 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56586388 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49483916 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.41735852 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37362600 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35387810 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34330040 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.32936770 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32907925 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.28873721 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23730345 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.16213288 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.12193498 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.11806233 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.11383507 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11152133 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11129949 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08132282 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05285249 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.05142237 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00513588 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97447161 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97322316 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.94369083 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92635769 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91355715 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90592462 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89636632 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86729943 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82617379 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82020008 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80608037 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78201882 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.77420696 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76981418 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73507396 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.71649043 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70056276 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.69759499 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69425825 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58010805 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56509543 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53658513 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51019638 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50923466 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47348741 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46365557 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45021494 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43949761 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43577036 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43207497 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42783681 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42423903 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42252293 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42064272 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41275033 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40845948 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37656380 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35432204 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35269299 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33118193 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.32734043 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.31706204 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31524349 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29769012 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28767576 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28357249 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28299606 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27135468 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27045808 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.26217212 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26009644 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24811793 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23885608 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23154834 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22775302 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22351620 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.21793237 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21763000 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20236643 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19305921 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08061742 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07361068 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.04561267 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.03000747 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02951445 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.02667176 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02293902 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0222963 |

